SCHEMBL4637377

SCHEMBL4637377

COc1cccc(C#Cc2nc3c(c(=O)[nH]c(=O)n3CC#CCCCO)n2C)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 4/20 0.40
ALDH1A1 P00352 3/20 0.40
NPSR1 Q6W5P4 2/20 0.40
KDM4E B2RXH2 2/20 0.40
ADORA3 P0DMS8 2/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
ADORA2B P29275 2/20 0.39
ADORA2A P29274 1/20 0.39
ADORA1 P30542 1/20 0.39
CYP2C9 P11712 1/20 0.38
PCSK9 Q8NBP7 1/20 0.38
XBP1 P17861 1/20 0.38
MAPT P10636 2/20 0.37
ALOX12 P18054 1/20 0.37
MAPK1 P28482 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
LMNA P02545 1/20 0.36
DAO P14920 1/20 0.36
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4636772 0.79 ALDH1A1 (0.42) HPGDALDH1A1NPSR1KDM4EKMT2A
SCHEMBL4637375 0.77 ADORA2A (0.41) HPGDALDH1A1NPSR1KDM4EADORA3
SCHEMBL2540252 0.75 ADORA1 (0.67) ADORA3ADORA2BADORA2AADORA1PCSK9
SCHEMBL2541029 0.73 ADORA1 (0.59) ADORA3ADORA2BADORA2AADORA1
SCHEMBL2537944 0.71 ADORA1 (0.44) ADORA3ADORA2BADORA2AADORA1
SCHEMBL4637264 0.71 MAOB (0.47) ALDH1A1ADORA3KMT2AMEN1ADORA2A
SCHEMBL4636181 0.71 ADORA2A (0.55) ADORA3ADORA2BADORA2AADORA1CYP2C9
SCHEMBL2537017 0.71 KDM4E (0.47) HPGDALDH1A1NPSR1KDM4EADORA3
SCHEMBL2537627 0.70 ADORA1 (0.57) ADORA2BADORA2AADORA1
SCHEMBL2539378 0.70 ADORA1 (0.56) ADORA3ADORA2BADORA2AADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1939197-A1 8-ethinylxanthine derivatives as selective A2A receptor antagonists SCHWARZ PHARMA AG (DE) 2008-07-02 EP disclosed